NCT02786199
Histological Differentiation Grade Predicted by Ultrasound Backscatterer Imaging No drug interventions Not Available Not Available unknown_status NCT02582827
QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 withdrawn NCT05450744
131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) treatment 1 recruiting NCT04084067
Indocyanine Green (ICG) Guided Tumor Resection diagnostic 1 recruiting NCT02159742
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases No drug interventions Not Available Not Available active_not_recruiting NCT03197363
Białystok PLUS - Polish Longitudinal University Study No drug interventions Not Available Not Available enrolling_by_invitation NCT01962103
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors treatment 1 / 2 completed NCT02049645
The Suitability of Sniff Dog as a Tool in Screening Tumors No drug interventions Not Available Not Available recruiting NCT02065297
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD) No drug interventions Not Available Not Available completed NCT00792649
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy No drug interventions Not Available Not Available unknown_status NCT02925234
The Drug Rediscovery Protocol (DRUP Trial) treatment 2 recruiting NCT00339989
Cervical Cancer Early Endpoints and Determinants No drug interventions Not Available Not Available completed NCT01523912
Radiofrequency Ablation for the Treatment of Gastric Dysplasia No drug interventions treatment 4 completed NCT01456143
Optical Imaging of Head and Neck Cancer No drug interventions treatment Not Available terminated NCT01577251
The Radiation Oncology Registry and Biosample Repository No drug interventions Not Available Not Available recruiting NCT01954836
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial No drug interventions treatment Not Available completed NCT02049658
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients No drug interventions Not Available Not Available recruiting NCT03415126
A Study of ASN007 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05158712
Genetic Factors and Pheochromocytomas in Neoplasia Type 2 No drug interventions Not Available Not Available recruiting NCT04341181
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling treatment 2 recruiting NCT03979014
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial No drug interventions prevention 3 unknown_status NCT02154022
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity No drug interventions Not Available Not Available enrolling_by_invitation NCT02851706
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System No drug interventions Not Available Not Available active_not_recruiting NCT05909202
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients No drug interventions supportive_care Not Available recruiting NCT02514603
A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers treatment 1 completed NCT02309164
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN). No drug interventions treatment Not Available completed NCT00143533
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors treatment 1 completed NCT01105533
A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors No drug interventions treatment 1 completed NCT02215733
The Use of Angiotensin Receptor Blockers and the Risk of Cancer Not Available Not Available completed NCT05013554
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors No drug interventions treatment 1 terminated NCT00496353
MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) No drug interventions treatment 1 / 2 completed NCT01269645
Facts and Attitudes About Clinical Trials No drug interventions supportive_care Not Available completed NCT01942005
EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients No drug interventions Not Available Not Available completed NCT00026897
Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer No drug interventions treatment 2 completed NCT03099161
Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) treatment 1 terminated NCT00004988
Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria No drug interventions treatment 1 completed NCT01395407
Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases No drug interventions treatment 1 completed NCT00694356
Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009) treatment 1 completed NCT02440685
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors treatment 1 / 2 terminated NCT01441115
ECI301 and Radiation for Advanced or Metastatic Cancer treatment 1 terminated NCT02743637
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors treatment 1 completed NCT00001500
Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits No drug interventions Not Available Not Available completed NCT00692159
Study of TRC102 in Combination With Pemetrexed in Cancer Patients treatment 1 completed NCT04280159
Modern Hybrid Imaging in Patients With OSCC No drug interventions Not Available Not Available completed NCT04717375
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT02747342
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer treatment 1 completed NCT00520299
Study of ADI-PEG 20 in Patients With Advanced Melanoma No drug interventions treatment 1 / 2 completed NCT00105599
Effectiveness of the FairCare System for Patients With Advanced Illness No drug interventions Not Available 2 completed NCT02699606
A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma treatment 2 completed NCT00028249
Process and Outcomes of Pain Management No drug interventions Not Available Not Available completed NCT00001336
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients No drug interventions Not Available Not Available completed NCT00199836
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. treatment 1 completed NCT00026936
A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning No drug interventions treatment 2 completed NCT00470613
Safety Study of Infusion of SGT-53 to Treat Solid Tumors No drug interventions treatment 1 completed NCT00080418
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer treatment 1 completed NCT00408434
Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT03251924
A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT04203524
Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients With Sepsis No drug interventions diagnostic Not Available unknown_status NCT01104116
Use of PET Imaging to Distinguish Malignant From Benign IPMN No drug interventions diagnostic Not Available terminated NCT01457196
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions No drug interventions diagnostic Not Available completed NCT00321958
Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer No drug interventions Not Available Not Available terminated NCT02536586
A Study of LY3023414 in Japanese Participants With Advanced Cancer treatment 1 completed NCT00100139
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer treatment 1 completed NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy treatment 3 completed NCT02759666
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors treatment 1 completed NCT00023166
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas treatment 1 terminated NCT00283465
A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy treatment 4 completed NCT00083720
Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy treatment 2 completed NCT02875327
Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data No drug interventions Not Available Not Available completed NCT00062491
Study of Karenitecin (BNP1350) to Treat Malignant Melanoma treatment 2 completed NCT05429762
Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors treatment 1 terminated NCT05450562
Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT00001580
Tissue Acquisition for Molecular Diagnostics No drug interventions Not Available Not Available completed NCT02226289
Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment treatment 2 unknown_status NCT00747292
Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery No drug interventions treatment 1 / 2 unknown_status NCT00448344
Family-supported Smoking Cessation for Chronically Ill Veterans No drug interventions treatment Not Available completed NCT00001444
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms treatment 1 completed NCT02759640
A Phase I Trial of HS-10241 in Solid Tumors No drug interventions treatment 1 completed NCT02578667
Gorbly Compression Device for Use in Image-guided Procedures No drug interventions Not Available Not Available withdrawn NCT04142567
Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation No drug interventions Not Available Not Available completed NCT01794104
Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT00573872
A Phase II Study of Spinal Radiosurgery No drug interventions treatment Not Available completed NCT00001572
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype treatment 1 completed NCT02955446
Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies Not Available Not Available no_longer_available NCT01163110
Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy No drug interventions treatment 1 completed NCT00988195
Study of Pegylated Human Recombinant Arginase for Liver Cancer treatment 1 completed NCT01708850
Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) treatment 4 completed NCT01117623
Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies Not Available 1 completed NCT01863303
Epidemiological Study of Colorectal Cancer in WuHan No drug interventions Not Available Not Available unknown_status NCT03637764
Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies treatment 1 / 2 terminated NCT01517464
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors No drug interventions treatment 1 completed NCT02394821
Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide supportive_care 3 completed NCT00695279
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products No drug interventions Not Available Not Available recruiting NCT00034879
Iressa Expanded Access Program (EAP) treatment 3 completed NCT00657254
Extension Program for Bay 43-9006 treatment 2 completed NCT01104077
Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) No drug interventions Not Available Not Available completed NCT02354547
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors treatment 1 suspended NCT05101798
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial diagnostic 2 recruiting NCT00407498
Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms No drug interventions treatment 1 completed NCT00226005
PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma treatment 2 completed NCT02473497
Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients Not Available Not Available no_longer_available NCT00694083
Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED) treatment 1 completed NCT01920061
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) basic_science 1 completed NCT00026871
Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System No drug interventions treatment 1 completed NCT02746185
Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban treatment 3 completed NCT03547037
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers treatment 1 completed NCT02377752
A Study of Olaratumab in Japanese Participants With Advanced Cancer treatment 1 completed NCT02450175
Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls basic_science Not Available unknown_status NCT02828449
Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy No drug interventions supportive_care Not Available unknown_status NCT02044536
Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy No drug interventions Not Available Not Available completed NCT01155713
Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT01287013
Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures No drug interventions diagnostic Not Available terminated NCT00408018
Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms No drug interventions treatment 1 terminated NCT02304419
A Study of Galunisertib on the Immune System in Participants With Cancer basic_science 1 completed NCT00001341
A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease treatment 1 completed NCT00026858
Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts No drug interventions treatment 2 completed NCT00001835
Oxaliplatin in Cancer Patients With Impaired Kidney Function treatment 1 completed NCT01287286
Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy No drug interventions treatment 2 / 3 unknown_status NCT02117648
A Study of LY2835219 in Participants With Cancer basic_science 1 completed NCT02684266
A Study of SHR6390 in Advanced Solid Tumor Patients treatment 1 completed NCT00961831
Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients No drug interventions diagnostic 1 completed NCT00270127
Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy treatment 3 completed NCT01092091
Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) treatment 1 / 2 completed NCT01672944
Evaluating Biobanking Educational Tools No drug interventions other Not Available completed NCT00936104
Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) No drug interventions Not Available Not Available completed NCT01693172
Effect of an Early Mobilization Program on Outcomes After Major Cancer Surgery No drug interventions prevention Not Available unknown_status NCT02434146
Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy supportive_care 1 / 2 terminated NCT00001695
Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials No drug interventions Not Available Not Available completed NCT00505414
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine treatment 3 terminated NCT00001150
Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers No drug interventions Not Available Not Available completed NCT04138823
A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) treatment 1 completed NCT01425008
Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma treatment 1 completed NCT00923065
Data Collection, Clinical Care and Interventions in CCR, NCI No drug interventions Not Available Not Available enrolling_by_invitation NCT01051635
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT01443468
Clinical and Genetic Studies of Li-Fraumeni Syndrome No drug interventions Not Available Not Available recruiting NCT01534598
FdCyd and THU for Advanced Solid Tumors treatment 1 completed NCT01943851
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies treatment 2 completed NCT02211755
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors treatment 1 recruiting NCT02423057
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors No drug interventions treatment 1 suspended NCT03194893
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer treatment 3 recruiting NCT03449381
This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors) treatment 1 recruiting NCT03468426
A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours treatment 1 completed NCT03964233
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) treatment 1 active_not_recruiting NCT04442425
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain No drug interventions Not Available Not Available completed NCT04465214
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer No drug interventions Not Available Not Available enrolling_by_invitation NCT05797246
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) treatment 2 recruiting NCT06018311
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads No drug interventions prevention Not Available active_not_recruiting NCT06161558
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT06546553
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. treatment 1 recruiting NCT04607421
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer treatment 3 active_not_recruiting NCT04958239
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer treatment 1 recruiting NCT05112965
An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C) treatment 3 recruiting NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT05386108
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast Cancer treatment 1 / 2 recruiting NCT05615376
Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have Undergone Cancer Therapy to Evaluate the Agreement Between QTc Measured Using 12 Lead Electrocardiogram (ECG) and a Wearable Device ECG No drug interventions diagnostic Not Available active_not_recruiting NCT05745909
Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy No drug interventions treatment Not Available completed NCT05999994
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer treatment 2 recruiting NCT06150157
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms No drug interventions treatment 1 recruiting NCT06170385
Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available recruiting NCT06287294
An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer No drug interventions Not Available Not Available recruiting NCT06376084
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC No drug interventions Not Available Not Available recruiting NCT06431594
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06482515
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue No drug interventions supportive_care 2 recruiting NCT03883243
Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung Cancer No drug interventions other Not Available unknown_status NCT00000603
Cord Blood Stem Cell Transplantation Study (COBLT) No drug interventions treatment 2 completed NCT02331303
A Drug Utilization Study of Radium-223 in Sweden No drug interventions Not Available Not Available completed NCT04853303
VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK No drug interventions treatment Not Available not_yet_recruiting NCT02025803
A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors treatment 1 completed NCT00715403
A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120 treatment 1 completed NCT03788603
Rogaratinib (BAY1163877) in Chinese Patients treatment 1 completed NCT03783403
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers treatment 1 active_not_recruiting NCT00437203
PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine treatment 1 terminated NCT02047890
Japanese BAY1000394 Monotherapy Phase I Study treatment 1 completed NCT04198090
Sexual & Gender Minority Competency in Oncology No drug interventions supportive_care Not Available completed NCT00207090
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer treatment 1 completed NCT00088790
AZD5438 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 completed NCT04495790
AIMS Cancer Outcomes Study No drug interventions Not Available Not Available recruiting NCT02241564
Malignancies in Transplanted Patients No drug interventions Not Available Not Available completed NCT01373164
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer treatment 1 / 2 completed NCT01088464
Study of IMC-11F8 in Participants With Advanced Solid Tumors treatment 1 completed NCT03495921
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide treatment 3 terminated NCT00210002
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced prevention 2 terminated NCT01324102
Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer Survivors No drug interventions treatment 1 / 2 completed NCT05573802
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma treatment 1 / 2 recruiting NCT00432302
Investigation of Mass Balance of the Test Drug and Major Metabolites treatment 1 completed NCT00507702
Identification of Key Blood Molecular Markers for Immunotherapy No drug interventions Not Available Not Available terminated NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT02171702
Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours treatment 1 completed NCT03895502
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study treatment 4 completed NCT01567384
A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies treatment 1 withdrawn NCT00879684
Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02314884
Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours No drug interventions treatment 1 unknown_status NCT01588184
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study treatment 4 completed NCT04309084
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma treatment 1 active_not_recruiting NCT00779584
A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) treatment 1 completed NCT04300179
Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt No drug interventions Not Available Not Available completed NCT02429479
Preparing Family Caregivers to Make Medical Decisions for Their Loved Ones No drug interventions supportive_care Not Available completed NCT05347979
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants treatment 1 completed NCT00730379
A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004) treatment 1 completed NCT00385879
The Effects of Case Management in a Medicaid Managed Care Plan No drug interventions supportive_care Not Available unknown_status NCT03282643
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients prevention 1 / 2 completed NCT01214343
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC treatment 3 unknown_status NCT00725387
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy No drug interventions Not Available Not Available completed NCT02307487
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients treatment 2 completed NCT00024687
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses treatment 1 withdrawn NCT02900287
Cancer Survival in Reunion Island , 1998-2008 (SUCRE) No drug interventions Not Available Not Available completed NCT03266887
Vitamin D Levels and Survival in Cancer Patients No drug interventions Not Available Not Available completed NCT00521287
Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection No drug interventions treatment 2 unknown_status NCT01280487
A Safety Study of Oral ZSTK474 in Patients With Cancer No drug interventions treatment 1 completed NCT05887687
68Ga-P3 PET/CT Imaging in Malignancy No drug interventions diagnostic Not Available recruiting NCT01362933
National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients No drug interventions Not Available Not Available completed NCT00767533
Immunobiology of Cancer No drug interventions Not Available Not Available terminated NCT01323933
First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02817633
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) treatment 1 recruiting NCT01695733
Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy supportive_care 1 terminated NCT00559533
A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors treatment 1 completed NCT02943733
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs treatment 1 terminated NCT00879554
A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03343054
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors treatment 1 completed NCT02390154
Roniciclib Mass Balance Study treatment 1 completed NCT02391454
Self-monitoring Physical Activity With a SMARTphone Application in Cancer Patients: a Feasibility Study (SMART) No drug interventions supportive_care Not Available completed NCT05277051
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT04572451
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma treatment 1 recruiting NCT00165451
A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer diagnostic 2 completed NCT00894153
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage No drug interventions treatment 4 unknown_status NCT01286753
A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation treatment 2 completed NCT01022853
Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors treatment 1 completed NCT02516553
BI 894999 First in Human Dose Finding Study in Advanced Malignancies No drug interventions treatment 1 completed NCT02471053
Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study No drug interventions treatment Not Available completed NCT00473577
Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients treatment 1 completed NCT01482377
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin treatment 1 completed NCT03077477
Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers No drug interventions treatment 1 withdrawn NCT02168777
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer treatment 1 terminated NCT00207077
Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors treatment 1 completed NCT06077877
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors treatment 1 / 2 recruiting NCT06444477
Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT00195247
Study Evaluating TTI-237 in Advanced Malignant Solid Tumors treatment 1 terminated NCT03220347
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas treatment 1 active_not_recruiting NCT00088647
Study Evaluating MST-997 in Advanced Malignant Solid Tumors treatment 1 terminated NCT04456647
Parenteral Nutrition Therapy in Patients With Incurable Cancer No drug interventions Not Available Not Available completed NCT05574647
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer No drug interventions diagnostic Not Available recruiting NCT00169845
Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients No drug interventions prevention 3 completed NCT02690545
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL No drug interventions treatment 1 / 2 recruiting NCT05902845
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL No drug interventions treatment 0 recruiting NCT03604445
This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours) No drug interventions treatment 1 terminated NCT01018745
Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan treatment 1 completed NCT01862198
The Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic Stent No drug interventions treatment 4 completed NCT03433898
This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer treatment 0 completed NCT04518098
STABLE (Strength Training and Balance Leg Exercise) Study No drug interventions prevention Not Available recruiting NCT03554005
Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009) treatment 1 completed NCT02129205
A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00677105
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. treatment 1 completed NCT03650205
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity prevention Not Available unknown_status NCT03336905
Implementation of a Program Based on Adapted Physical Activity and Recommendations for Second Cancers Prevention for TYACs No drug interventions prevention Not Available completed NCT03814005
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems other 1 completed NCT02760797
A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors treatment 1 completed NCT05017597
Online Cancer-Related Fatigue Management No drug interventions supportive_care Not Available withdrawn NCT02134197
Dose-escalation Study of Lupartumab Amadotin (BAY1129980) No drug interventions treatment 1 terminated NCT02961283
Study of ASN003 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03138083
OMO-1 in Solid Malignancies treatment 1 / 2 terminated NCT05280483
ABSK021 Food Effect Study in Healthy Subjects other 1 completed NCT06341283
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer Not Available Not Available not_yet_recruiting NCT01086683
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course No drug interventions supportive_care 2 / 3 completed NCT00969761
BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumour treatment 1 completed NCT00547261
Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer No drug interventions treatment 1 terminated NCT00400361
A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors. treatment 1 completed NCT02479061
An Observational Study of the Prevalence of Patients Requiring Palliative Care in French Anti-cancer Centers. No drug interventions Not Available Not Available completed NCT01049061
A Study of MORAb-003 in Patients With Solid Tumor treatment 1 completed NCT03614728
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) treatment 1 / 2 terminated NCT01764828
BAY86-9766 Plus Gemcitabine Phase I Study in Asian other 1 completed NCT05898828
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer treatment 1 / 2 withdrawn NCT00042328
A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients treatment 2 completed NCT03210428
Quantitative MR Imaging in Locally Advanced Cervical Cancer No drug interventions Not Available Not Available unknown_status NCT02171728
Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors treatment 1 completed NCT02530411
Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer treatment 2 unknown_status NCT00421811
A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan treatment 1 / 2 completed NCT03190811
Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors No drug interventions treatment 1 / 2 completed NCT01728311
Open Label Study of BAY1082439 in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT00687011
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594) prevention 4 completed NCT01561911
A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment No drug interventions Not Available 1 completed NCT00194493
Computerized Assessment for Patients With Cancer No drug interventions treatment 3 completed NCT01837693
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 No drug interventions screening Not Available unknown_status NCT05147493
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment treatment 2 not_yet_recruiting NCT00594971
A Shared Care Approach for Seriously Ill Cancer Patients Between General Practice, Discharge Department and a Specialist Palliative Care Team No drug interventions health_services_research Not Available withdrawn NCT06496971
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients treatment 3 not_yet_recruiting NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT03391778
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study No drug interventions other 1 recruiting NCT03872778
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake treatment 1 / 2 recruiting NCT01964378
CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer treatment 3 terminated NCT02798978
A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects No drug interventions treatment 1 completed NCT00625378
Sorafenib Long Term Extension Program treatment 3 completed NCT03911388
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors treatment 1 active_not_recruiting NCT02273388
BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours treatment 1 completed NCT03085888
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types No drug interventions Not Available Not Available active_not_recruiting NCT01120288
A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases No drug interventions treatment 1 completed NCT00067288
Meaning-Centered Psychotherapy in Advanced Cancer No drug interventions educational_counseling_training 2 completed NCT05878288
Deep sequencIng in Cutaneous Squamous CEll caRciNomas other 2 active_not_recruiting NCT03712488
Differential Expression of CD200 in B-chronic Lymphoproliferative Disorders by Multicolour Flow Cytometry No drug interventions Not Available Not Available unknown_status NCT04831307
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical No drug interventions other Not Available unknown_status NCT04711109
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation prevention 3 recruiting NCT02585609
Sleep Quality in Patients With Advanced Cancer No drug interventions Not Available Not Available completed NCT04526509
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors treatment 1 terminated NCT02001909
Effect of Neomycin on the Pharmacokinetics of Regorafenib Not Available 1 completed NCT00748709
Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification. treatment 2 terminated NCT00102609
A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma treatment 1 completed NCT01774409
Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer No drug interventions diagnostic Not Available recruiting NCT02043756
Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection treatment 1 completed NCT03389256
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC treatment 2 unknown_status NCT02871856
International Lung Screen Trial (ILST) No drug interventions screening Not Available active_not_recruiting NCT00091585
Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors. treatment 1 completed NCT00147485
A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer treatment 1 terminated NCT02592785
Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT03307785
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 treatment 1 active_not_recruiting NCT01026415
Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) treatment 1 completed NCT02548715
Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery treatment 2 / 3 withdrawn NCT06247215
Development of a Culturally Tailored Resilience-building Intervention for Chinese American's Advance Care Planning Discussions No drug interventions supportive_care Not Available not_yet_recruiting NCT01968915
Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors treatment 1 completed NCT02254915
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I No drug interventions treatment 3 withdrawn NCT01151215
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer treatment 2 terminated NCT05131815
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT00573937
Methadone Versus Morphine for Cancer-Related Pain treatment 2 terminated NCT02171637
Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors treatment 1 completed NCT04133337
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC treatment 1 / 2 unknown_status NCT00078637
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma treatment 1 completed NCT01538537
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer treatment 1 completed NCT01460537
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer treatment 1 completed NCT03250832
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors treatment 1 completed NCT04493632
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. No drug interventions Not Available Not Available recruiting NCT04996732
Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry No drug interventions Not Available Not Available recruiting NCT02031432
CORAL XT - Open-label Extension Trial of the CORAL Trial treatment 3 completed NCT00087932
Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer Treatment No drug interventions Not Available Not Available completed NCT00726752
A Study In Patients With Advanced Solid Tumor treatment 1 completed NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT02674152
Dose Finding Study of BI 836880 in Patients With Solid Tumors treatment 1 completed NCT01188252
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies treatment 1 completed NCT04039100
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease No drug interventions supportive_care Not Available completed NCT02490800
Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma treatment 1 / 2 completed NCT00095459
BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors treatment 1 completed NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT05755659
Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV. prevention Not Available recruiting NCT02211859
Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit treatment 1 completed NCT00481559
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity Not Available Not Available approved_for_marketing NCT01169675
BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours treatment 1 completed NCT05581875
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory treatment 1 / 2 not_yet_recruiting NCT00424775
A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066) treatment 1 terminated NCT02330575
Alberta Cancer Exercise Pilot Randomized Trial No drug interventions treatment Not Available completed NCT06329570
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) treatment 1 / 2 not_yet_recruiting NCT05537870
The Effectiveness of Nurse Navigators in Cancer Care No drug interventions treatment Not Available completed NCT01585870
Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination treatment 1 completed NCT03308942
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants treatment 2 completed NCT06551142
A Study of GSK5764227 in Participants With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT01995942
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial No drug interventions Not Available Not Available unknown_status NCT02696642
Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment treatment 1 completed NCT04673942
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors No drug interventions treatment 2 recruiting NCT02775799
National Swiss Sarcoma Cohort Study No drug interventions Not Available Not Available terminated NCT05993299
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma treatment 2 active_not_recruiting NCT03709706
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab treatment 1 / 2 terminated NCT00574106
A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment No drug interventions treatment 1 unknown_status NCT00359606
5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer treatment 1 completed NCT00099606
Phase I (PH I) Mad Refractory Solid Tumor Study treatment 1 completed NCT01688206
A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT05475106
Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms No drug interventions treatment 0 recruiting NCT04141449
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation No drug interventions health_services_research 2 recruiting NCT00398749
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2) Not Available Not Available completed NCT06035549
Resilience in East Asian Immigrants for Advance Care Planning Discussions No drug interventions supportive_care Not Available not_yet_recruiting NCT02629549
Intraoperative Imaging of Pituitary Adenomas by OTL diagnostic 1 terminated NCT04449549
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel treatment 2 recruiting NCT00511849
Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors treatment 1 completed NCT04704349
Latest Imaging SPECT System Evaluation Phase 1 No drug interventions other Not Available completed NCT01911936
A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors treatment 1 completed NCT02265536
A Study of LY3022855 In Participants With Breast or Prostate Cancer No drug interventions basic_science 1 completed NCT00448136
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. treatment 2 completed NCT03666936
Facilitate the Return to Work of Cancer Survivors No drug interventions treatment Not Available completed NCT03803436
Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation No drug interventions treatment 2 recruiting NCT04618913
Anticoagulation in Patients With Venous Thromboembolism and Cancer Not Available Not Available active_not_recruiting NCT01043913
Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue No drug interventions treatment 2 completed NCT00117013
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a treatment 1 completed NCT01944813
Advance Care Planning: A Way to Improve End-of-life Care Life Care No drug interventions supportive_care Not Available unknown_status NCT00735813
Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia No drug interventions prevention 3 completed NCT03441113
Extended Access of Momelotinib in Adults With Myelofibrosis treatment 2 active_not_recruiting NCT02964013
Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) treatment 1 completed NCT03926013
A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors No drug interventions treatment 1 completed NCT03968718
PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice No drug interventions health_services_research Not Available unknown_status NCT02416518
Genetic Exploration of the Molecular Basis of Malignancy in Adults No drug interventions Not Available Not Available completed NCT05519618
Multi-modality Evaluation of Flow Rate, Pressure and Size of Spine Epidural Venous Plexus No drug interventions Not Available Not Available unknown_status NCT04456218
Clinical Evaluation of a Custom-made and Disposable Endoscope System for Biliary Tract No drug interventions diagnostic Not Available completed NCT02485119
Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies treatment 1 completed NCT02602119
Intraoperative Imaging of Pulmonary Nodules by OTL38 diagnostic 1 completed NCT00528619
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors treatment 1 completed NCT02171741
Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid Tumors treatment 1 completed NCT03961841
Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma No drug interventions treatment 3 not_yet_recruiting NCT02192541
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas treatment 1 terminated NCT06044441
Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG) No drug interventions health_services_research Not Available recruiting NCT02091141
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors treatment 2 completed NCT02717741
A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor No drug interventions Not Available 1 unknown_status NCT02899117
Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-Being No drug interventions supportive_care Not Available completed NCT04932317
Oral Symptom Assessment Scale (OSAS): Validity and Reliability No drug interventions Not Available Not Available completed NCT00716417
Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours treatment 1 completed NCT02487017
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT00266617
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy treatment 2 completed NCT05391217
Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors No drug interventions Not Available Not Available recruiting NCT04204434
Biomarkers For Immune Checkpoint Inhibitors No drug interventions Not Available Not Available completed NCT04147234
A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors) treatment 1 completed NCT00040534
Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED) No drug interventions treatment 1 terminated NCT00490334
Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer No drug interventions Not Available Not Available completed NCT00065234
Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus) No drug interventions prevention 2 terminated NCT00443534
A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol. treatment Not Available completed NCT02972034
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013) treatment 1 completed NCT02567734
Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors No drug interventions treatment Not Available unknown_status NCT04442724
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy No drug interventions treatment Not Available recruiting NCT03697824
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a treatment 2 withdrawn NCT00674024
Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function treatment 1 completed NCT00701324
BI 811283 in Various Solid Tumours No drug interventions treatment 1 completed NCT02219724
A Study to Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT02960724
uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer No drug interventions diagnostic 2 unknown_status NCT03208816
Community-Led Action Research in Oncology: Improving Symptom Management No drug interventions supportive_care Not Available completed NCT00898716
Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan treatment 1 completed NCT04446416
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients treatment Not Available completed NCT03416816
A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile No drug interventions treatment 1 terminated NCT03384316
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer treatment 1 completed NCT01214616
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours treatment 1 completed NCT03366116
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02192216
The Effect of Resistance Training and Aerobic Training on Body Composition During Chemotherapy No drug interventions supportive_care Not Available terminated NCT05836896
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies No drug interventions treatment 1 recruiting NCT00998296
Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours. treatment 1 completed NCT01346358
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03948958
PREMO Study: to Investigate Port REMoval Outcomes No drug interventions prevention Not Available completed NCT05919758
Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix No drug interventions Not Available Not Available recruiting NCT01003158
Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. treatment 1 completed NCT02494258
A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders treatment 2 active_not_recruiting NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients No drug interventions supportive_care Not Available completed NCT02110758
Evaluating the Impact of Patient-Centered Oncology Care No drug interventions Not Available Not Available completed NCT01023958
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer treatment 2 completed NCT01974258
Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients treatment 1 withdrawn NCT04763135
Mirtazapine in Cancer-related Poly-symptomatology treatment 3 terminated NCT05602935
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study treatment 2 active_not_recruiting NCT05827835
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases No drug interventions treatment 2 recruiting NCT02129335
Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner No drug interventions Not Available Not Available terminated NCT03416335
A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile treatment 1 / 2 terminated NCT00684463
Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED) prevention 4 completed NCT01772563
Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours treatment 1 completed NCT02644863
Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer treatment 2 unknown_status NCT00960063
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) treatment 1 terminated NCT00055263
A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies treatment 1 completed NCT04350463
A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers treatment 2 completed NCT01538563
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer treatment 1 completed NCT02429063
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study No drug interventions supportive_care Not Available completed NCT04151186
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors treatment Not Available unknown_status NCT03072186
Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base Surgery No drug interventions diagnostic Not Available completed NCT01309386
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants treatment 3 completed NCT02221986
Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer Treatment No drug interventions treatment Not Available completed NCT00862186
Self-Management of Cancer-Related Fatigue by Adolescents No drug interventions supportive_care Not Available completed NCT00425139
Evaluation of a Video Game for Adolescents and Young Adults With Cancer No drug interventions supportive_care Not Available completed NCT01813539
A Study of ARGX-110 in Participants With Advanced Malignancies treatment 1 / 2 completed NCT00117039
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia treatment 4 completed NCT05066139
Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) No drug interventions supportive_care Not Available recruiting NCT00590239
Barrett's Esophagus Related Neoplasia (BERN) Project No drug interventions Not Available Not Available recruiting NCT00740922
Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers No drug interventions Not Available Not Available completed NCT02222922
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors treatment 1 completed NCT01303822
Mindfulness-based Stress Reduction in Cancer Treatment No drug interventions treatment Not Available completed NCT01868022
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling treatment 1 completed NCT05374122
AI Guidance for Biopsy in Suspected Cholangiocarcinoma No drug interventions diagnostic Not Available active_not_recruiting NCT06177925
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC treatment 2 recruiting NCT01722825
Study of LY2157299 in Japanese Participants With Cancer treatment 1 completed NCT01096030
Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors treatment 1 completed NCT05187130
The Effect of Mindfulnes Program on Stress, Depression and Psychological Well-being in Cancer Patients No drug interventions supportive_care Not Available completed NCT00578630
Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients No drug interventions Not Available Not Available completed NCT00349830
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy No drug interventions Not Available Not Available recruiting NCT00124930
Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer treatment 3 terminated NCT02632448
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer basic_science 1 / 2 recruiting NCT00607048
Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors treatment 1 completed NCT00024648
Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies treatment 1 completed NCT03402048
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial treatment 3 unknown_status NCT02909348
Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab Not Available Not Available completed NCT01725048
Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer supportive_care 0 completed NCT02952248
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours treatment 1 completed NCT01688557
Trial on Innovative Technologies in Colonoscopy No drug interventions diagnostic Not Available completed NCT02859857
Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT02806557
Profiling Neutrophil Counts in Patients on Chemotherapy No drug interventions Not Available Not Available unknown_status NCT04194957
Improving the Safety of Fluoropyrimidine-based Chemotherapy treatment Not Available unknown_status NCT01795157
Computer Based Assessment and Treatment No drug interventions diagnostic Not Available completed NCT00773526
A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors. treatment 1 completed NCT02587026
Biorepository for Precision Genomics No drug interventions Not Available Not Available terminated NCT04462926
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed No drug interventions diagnostic Not Available recruiting NCT00399126
Phase I Trial of Paclitaxel With Perifosine treatment 1 completed NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00237926
Comparing Aerobic to Resistance Training in Recovery From Cancer No drug interventions Not Available Not Available completed NCT00721266
A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors. treatment 1 completed NCT06004466
Noninvasive Internal Jugular Venous Oximetry No drug interventions Not Available Not Available recruiting NCT06365866
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. No drug interventions treatment Not Available recruiting NCT03954366
Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives other 1 completed NCT02315066
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 treatment 1 completed NCT01403974
Phase I Trial of BI 836845 for Various Solid Cancer No drug interventions treatment 1 completed NCT03099174
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer treatment 1 completed NCT02133274
A Psychosocial Intervention Plus Early Palliative Care in the Reduction of Depression of Advanced Cancer Patients No drug interventions supportive_care Not Available terminated NCT00985374
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors treatment 1 terminated NCT02437474
Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study No drug interventions Not Available Not Available completed NCT00024674
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days treatment 1 withdrawn NCT04318574
The Effects of a 6-week Balance, Agility, Strengthening Exercise Class No drug interventions treatment Not Available unknown_status NCT06203574
Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors No drug interventions diagnostic Not Available recruiting NCT01317420
Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types No drug interventions treatment 1 completed NCT06237920
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab treatment 2 recruiting NCT02622620
Study on Neuroepithelial Tumor Grading and Pseudoprogression After Glioma Therapy Using Advanced Functional MRI Techniques No drug interventions Not Available Not Available unknown_status NCT00377520
A Trial for Patients With Advanced/Recurrent Endometrial Cancer treatment 2 completed NCT00032682
Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics No drug interventions Not Available Not Available completed NCT04008082
A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma Not Available Not Available completed NCT03757182
Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients No drug interventions Not Available Not Available active_not_recruiting NCT00378482
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. treatment 2 completed NCT00097682
Views of Cancer Patients Regarding Financial Conflicts of Interest No drug interventions Not Available Not Available completed NCT02221882
A Study of LY3164530 in Participants With Cancer No drug interventions treatment 1 completed NCT00041782
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients treatment 2 terminated NCT03166631
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread treatment 1 terminated NCT02659631
PF-06671008 Dose Escalation Study in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT02403531
Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer treatment 2 completed NCT03469531
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer treatment 2 unknown_status NCT00030173
A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors treatment 1 completed NCT06236373
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia No drug interventions Not Available Not Available recruiting NCT04179773
Chemotherapy and Liver Cirrhosis in Frequently-associated Cancers No drug interventions Not Available Not Available recruiting NCT00900627
Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) treatment 1 / 2 completed NCT00050427
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer treatment 2 completed NCT00047476
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients treatment 2 completed NCT02257476
Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors treatment 1 completed NCT02581176
Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study treatment 4 completed NCT03270176
A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy treatment 1 completed NCT00390676
A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine treatment 1 completed NCT01915576
Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients No drug interventions treatment 1 completed NCT04397276
A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT01971476
Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known treatment 1 completed NCT03744676
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007) treatment 2 completed NCT04627376
Multimodal Program for Cancer Related Cachexia Prevention No drug interventions prevention Not Available recruiting NCT00195260
Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors treatment 1 completed NCT04724460
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer No drug interventions treatment 4 active_not_recruiting NCT05343260
Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery prevention Not Available unknown_status NCT01815294
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer treatment 1 completed NCT01279291
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer treatment 1 terminated NCT00384891
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer No drug interventions treatment 3 terminated NCT01394991
A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia treatment 4 completed NCT05912062
Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer Not Available Not Available recruiting NCT00099762
Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia No drug interventions Not Available Not Available completed NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors treatment 1 completed NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC treatment 1 / 2 active_not_recruiting NCT01234480
Intended Use Study of the BD SurePath Plus™ Pap No drug interventions diagnostic Not Available terminated NCT02491580
Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer No drug interventions Not Available Not Available completed NCT06175780
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT02369029
BAY1238097, First in Man No drug interventions treatment 1 terminated NCT05830929
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients No drug interventions other Not Available recruiting NCT06285929
ACS Community Access to Resources Education and Support No drug interventions Not Available Not Available enrolling_by_invitation NCT00001189
The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors No drug interventions treatment 2 completed NCT03336489
Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks No drug interventions Not Available Not Available completed NCT00389389
Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors No drug interventions treatment 1 completed NCT02657889
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer treatment 1 / 2 completed NCT01288989
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00341692
Studying Normal Breast Tissue and Cancer Risk No drug interventions Not Available Not Available completed NCT04310592
Natural Killer Cell (CYNK-001) Infusions in Adults With AML treatment 1 recruiting NCT00989092
Darbepoetin Alfa and Anemia of Cancer supportive_care 2 terminated NCT02092792
A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors No drug interventions treatment 1 completed NCT01618344
Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer No drug interventions Not Available Not Available completed NCT02042144
Safety and Effectiveness of Regorafenib Not Available Not Available completed NCT05514444
Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) treatment 1 active_not_recruiting NCT04192344
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor treatment 1 recruiting NCT02825940
A Study to Assess the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Administered Intravenously (IV) as a Single Agent or in Combination With Chemotherapy in Chinese Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT02558140
A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT03037840
Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients No drug interventions Not Available Not Available unknown_status NCT01445340
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma treatment 1 terminated NCT02458040
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs No drug interventions Not Available Not Available withdrawn NCT06114940
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC treatment 2 recruiting NCT03782467
Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015 No drug interventions treatment 1 completed NCT04061967
SMS-based Summons in Cervical Screening No drug interventions prevention Not Available recruiting NCT06234267
Eat, Play, Sleep: A Text Message Approach to Promoting Health Behaviors for Cancer Survivors and Their Caregivers No drug interventions supportive_care Not Available recruiting NCT02739867
Tumor-educated Platelets in Venous Thromboembolism No drug interventions Not Available Not Available completed NCT00982267
A Trial Of SU14813 In Patients With Advanced Solid Malignancies No drug interventions treatment 1 completed NCT02688101
Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors treatment 1 completed NCT02516501
Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition No drug interventions treatment Not Available completed NCT04448301
PC001- A Study to Evaluate the Usability of PointCheck No drug interventions diagnostic Not Available completed NCT05887401
Physical Activity and Healthy Eating Among Young Adult Cancer Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT01291901
NP2 Enkephalin For Treatment of Intractable Cancer Pain No drug interventions treatment 2 completed NCT00125801
The Pain Pen for Breakthrough Cancer Pain treatment 3 terminated NCT03027401
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics No drug interventions Not Available Not Available withdrawn NCT01234701
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI) No drug interventions Not Available Not Available completed NCT00677001
A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. treatment 1 completed NCT05964101
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma treatment 2 recruiting NCT02500004
Brown Adipose Tissue Activity and Energy Metabolism in Cachexia No drug interventions diagnostic Not Available completed NCT02333604
Cancer Experience Registry (CER) for Cancer Patients and Caregivers No drug interventions Not Available Not Available recruiting NCT00264472
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors No drug interventions treatment 1 suspended NCT04222972
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT02211872
BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit treatment 1 completed NCT00644072
SNX-5422 to Treat Solid Tumor Cancers and Lymphomas treatment 1 completed NCT00100672
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer treatment 1 completed NCT03493672
Counting Steps! Integration of Objectively Assessed Physical Activity and Fitness With Smartphones in Clinical Oncology Practice. No drug interventions Not Available Not Available completed NCT03648372
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System treatment 1 / 2 terminated NCT02621268
Minimally Invasive Imagery With Indocyanine Green diagnostic 1 completed NCT02170168
The Orkdal Model. Collaboration Between Specialist and Community Care Within Palliative Cancer Care No drug interventions Not Available Not Available completed NCT01962168
Evolution® Biliary Stent System Clinical Study No drug interventions Not Available Not Available completed NCT00938769
Enhanced Self-Efficacy Training No drug interventions health_services_research Not Available completed NCT05816369
Oral Nutritional Supplement Preferences in Patients With Cancer No drug interventions supportive_care Not Available recruiting NCT04404569
Continued Treatment for Participants Enrolled in Studies of BXQ-350 treatment 1 enrolling_by_invitation NCT02459769
Exercise Intervention for LGBT Cancer Survivors No drug interventions supportive_care Not Available completed NCT02765269
Intelligent Pain Management System for Assessing Pain in Cancer Patients No drug interventions health_services_research Not Available completed NCT01586546
A Pilot Study To Assess Guidance in and Subsequent Use of Mind-Body Techniques on the Quality of Life of Cancer Patients No drug interventions supportive_care Not Available terminated NCT00939146
Outlook: An Intervention to Improve Quality of Life in Serious Illness No drug interventions Not Available Not Available completed NCT01853046
Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment treatment 1 completed NCT02122146
A Study Of PF-06664178 In Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT04811846
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood No drug interventions treatment Not Available recruiting NCT04697446
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC No drug interventions Not Available Not Available unknown_status NCT03693612
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors treatment 1 / 2 completed NCT02740712
Pharmacokinetic Drug-Drug Interaction Study of Rucaparib other 1 completed NCT06149312
Feasibility of an Advance Care Planning Intervention No drug interventions supportive_care Not Available recruiting NCT02410512
A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT00676910
A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors. treatment 1 completed NCT03674710
A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques No drug interventions diagnostic Not Available unknown_status NCT01411410
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer treatment 1 completed NCT04146610
Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid Tumors treatment 1 unknown_status NCT01103310
Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation No drug interventions diagnostic 1 completed NCT03739710
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT02348710
Exercise Intervention for Cancer Survivors No drug interventions supportive_care Not Available completed NCT00257881
Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 terminated NCT00420381
Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT02929381
Advanced Endoscopic Imaging in Colonoscopy No drug interventions diagnostic Not Available unknown_status NCT01789281
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. treatment 4 completed NCT01179295
Japanese BAY86-9766 Monotherapy Phase I Study treatment 1 completed NCT02081495
A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer treatment 1 completed NCT00057395
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT00065195
REST: Reducing End-of-Life Symptoms With Touch No drug interventions treatment 2 completed NCT04537195
Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer Patients No drug interventions treatment Not Available recruiting NCT01811095
A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing No drug interventions Not Available Not Available completed NCT00050414
A Study of Trabectedin in Patients With Advanced Ovarian Cancer treatment 2 completed NCT03447314
Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors treatment 1 completed NCT00088114
STA-4783 and Paclitaxel for Treatment of Solid Tumors treatment 1 completed NCT02082314
Prospective Study Determining the Pain Response, Functional Interference and Quality of Life in Patients Undergoing Radiofrequency Ablation Assisted Vertebroplasty/ Cementoplasty No drug interventions Not Available Not Available completed NCT03942614
Nordic Pole Walking for Individuals With Cancer No drug interventions supportive_care Not Available completed NCT00493155
A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors. No drug interventions treatment 1 completed NCT01030055
Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT01028755
To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03299855
MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric? No drug interventions other Not Available completed NCT04595955
Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life No drug interventions health_services_research Not Available completed NCT01337050
Asian Phase I Study Of PF-03446962 basic_science 1 completed NCT02828150
Integrative Parenteral Nutrition in Cancer Patients No drug interventions treatment Not Available completed NCT03359850
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients treatment 1 completed NCT02171650
BIBW 2992 in Patients With Advanced Solid Tumors treatment 1 completed NCT02612350
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease No drug interventions Not Available Not Available completed NCT00088023
Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness treatment 1 terminated NCT01514123
Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors treatment 1 completed NCT00756223
Phase I Study of BI 831266 in Patients With Advanced Solid Tumours No drug interventions treatment 1 completed NCT02875223
A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas treatment 1 terminated NCT00178308
Measuring Alterations of DNA in Human Blood No drug interventions Not Available Not Available completed NCT02760238
Myeloproliferative Neoplasms (MPNs) Patient Registry No drug interventions Not Available Not Available recruiting NCT03168438
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma treatment 1 terminated NCT05838638
Serious Gaming for Chemotherapy-induced Nausea and Vomiting No drug interventions supportive_care Not Available recruiting NCT01938638
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT04080843
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients treatment 2 completed NCT03826043
THrombo-Embolic Event in Onco-hematology No drug interventions screening Not Available completed NCT01343043
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma treatment 1 completed NCT02992743
Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma treatment 2 completed NCT04730843
A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00127543
Kid Cards: Teaching Kids About Medicines No drug interventions other Not Available withdrawn NCT05441943
Lymphaticovenous Anastomosis as Treatment for Lymphedema No drug interventions treatment Not Available active_not_recruiting NCT01358903
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors No drug interventions treatment 1 completed NCT05907603
Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) No drug interventions treatment 0 recruiting NCT01646203
A Study of IMC-TR1 in Participants With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05573503
Effects of a Web Based Education Programme About Sexuality Aimed at Nurses That Care for Patients With Cancer No drug interventions health_services_research Not Available enrolling_by_invitation NCT04787003
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors treatment 1 recruiting NCT00350090
A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy. treatment 3 terminated NCT05943990
Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma treatment 1 terminated NCT01404390
Japanese BAY80-6946 Monotherapy Phase I Study treatment 1 completed NCT00532090
A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors. treatment 1 completed NCT01734564
Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors treatment 2 completed NCT05729464
Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism No drug interventions Not Available Not Available recruiting NCT00038064
Anemia in Patients With a Non-Myeloid Malignancy treatment 3 completed NCT01739764
An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol treatment 4 completed NCT02723864
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors treatment 1 completed NCT00730821
Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors treatment 1 completed NCT02836821
Effect of Rifampicin on the Pharmacokinetics of Apatinib treatment 1 completed NCT00225121
Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors treatment 1 completed NCT01392521
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancer treatment 1 completed NCT00450502
Safety of Batracylin in Patients With Solid Tumors and Lymphomas treatment 1 completed NCT01567202
Study of DC Vaccination Against Glioblastoma No drug interventions treatment 2 unknown_status NCT02366884
Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011) treatment 2 unknown_status NCT04181684
LITT Followed by Hypofractionated RT for Recurrent Gliomas No drug interventions treatment Not Available recruiting NCT02715284
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors treatment 1 recruiting NCT00630084
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma treatment 4 completed NCT01999179
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis health_services_research Not Available completed NCT00417079
XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer treatment 3 completed NCT00001579
A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors treatment 1 completed NCT02837679
Oncogeriatric Intervention and Follow-up at Home No drug interventions treatment Not Available unknown_status NCT01299987
Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients With Small Breast Cancer No drug interventions treatment Not Available completed NCT00210587
An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation treatment 3 completed NCT00399087
Phase I Trial of Docetaxel With Perifosine treatment 1 completed NCT00001387
Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy treatment 1 completed NCT00179387
Mind-Body Program for Cancer Patients No drug interventions supportive_care Not Available completed NCT01164033
A Study of RO5045337 in Patients With Solid Tumors treatment 1 completed NCT04482933
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma treatment 2 not_yet_recruiting NCT03303833
The GEOLynch Cohort Study No drug interventions Not Available Not Available recruiting NCT02077933
Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors treatment 1 completed NCT04388033
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. treatment 1 / 2 unknown_status NCT00264433
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent treatment 2 completed NCT01383733
A Study of RO5458640 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00875433
Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours treatment 2 completed NCT00809133
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours treatment 1 completed NCT01304654
ALI/ARDS in Oncologic Pediatric Patients No drug interventions Not Available Not Available unknown_status NCT02280954
Indocyanine Green for Solid Tumors diagnostic 1 completed NCT01828554
Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight basic_science Not Available completed NCT03553654
Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity No drug interventions diagnostic Not Available completed NCT00503451
A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors treatment 1 completed NCT05442151
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts No drug interventions diagnostic Not Available recruiting NCT02630251
Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors No drug interventions treatment 1 terminated NCT00386451
Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure No drug interventions treatment Not Available completed NCT05907551
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions No drug interventions Not Available Not Available recruiting NCT02898051
Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism No drug interventions Not Available Not Available unknown_status NCT04446351
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT04931251
Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings No drug interventions health_services_research Not Available recruiting NCT01143753
A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors No drug interventions treatment 1 completed NCT00106353
Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors treatment 1 / 2 completed NCT01524653
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) prevention 2 completed NCT01251653
A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel Not Available Not Available completed NCT02203253
Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting prevention 3 completed NCT02526953
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients treatment 3 unknown_status NCT00969553
Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers treatment 1 completed NCT04772053
Molecular Disease Characterization Initiative (MDCI) No drug interventions other 2 terminated NCT02082977
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma No drug interventions treatment 1 terminated NCT02020577
Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours treatment 1 completed NCT04627077
Livestrong Cancer Institutes' Patient Reported Outcomes Study No drug interventions Not Available Not Available completed NCT01240577
An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas treatment 1 completed NCT03403777
Avelumab in Refractory Testicular Germ Cell Cancer. treatment 2 completed NCT00321347
Intravenous (IV) Lidocaine for Opioid-refractory Pain treatment 2 withdrawn NCT01348347
BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours treatment 1 completed NCT04147247
A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread No drug interventions treatment 1 completed NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) treatment 1 active_not_recruiting NCT00040547
Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED) No drug interventions treatment 1 completed NCT00291447
111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen No drug interventions treatment 1 completed NCT00071045
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members No drug interventions Not Available Not Available recruiting NCT01702545
Determination of Drugs and Their Metabolites in Hospitalized Patients No drug interventions Not Available Not Available unknown_status NCT02543645
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer treatment 1 terminated NCT02944045
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients treatment 3 unknown_status NCT02106845
Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors. treatment 1 completed NCT01966445
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors No drug interventions treatment 1 completed NCT00516945
A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers treatment Not Available completed NCT01445145
An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection No drug interventions Not Available Not Available completed NCT00940498
Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors treatment 1 completed NCT00900198
Collection of Tissue Samples for Cancer Research No drug interventions Not Available Not Available recruiting NCT01287598
BAY73-4506 Probe Substrate Study treatment 1 completed NCT00906698
Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2 treatment 1 completed NCT02647398
Study Comparing Two Strategies of Exercise in Breast and Colon Cancer Survivors and Their Impact on Fatigue No drug interventions supportive_care Not Available completed NCT01123005
Imaging and Biomarkers of Hypoxia in Solid Tumors diagnostic 1 terminated NCT03569605
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies No drug interventions supportive_care Not Available completed NCT04991805
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study No drug interventions Not Available Not Available completed NCT02689505
Weekly BI 836880 in Patients With Advanced Solid Tumors treatment 1 completed NCT00557505
A Study Of PF-03732010 In Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00120705
Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy treatment 2 completed NCT06048705
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer treatment 1 terminated NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study No drug interventions Not Available Not Available recruiting NCT05675605
A Study of TY-1091 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01695005
A Study of LY3039478 in Participants With Advanced Cancer treatment 1 completed NCT06285097
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors treatment 1 recruiting NCT00141297
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer treatment 1 completed NCT00269997
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug treatment 2 completed NCT00398697
Phase I Perifosine and Gemcitabine Study treatment 1 completed NCT04008797
A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor treatment 1 recruiting NCT02663297
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas No drug interventions treatment 1 active_not_recruiting NCT05298683
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor treatment 2 not_yet_recruiting NCT02507583
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma No drug interventions treatment 1 completed NCT04267861
M7824 Related Adverse Effects in Adults With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04154761
Resection of the Inferior Vena Cava Due to Tumor Involvement No drug interventions Not Available Not Available completed NCT02752061
Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care No drug interventions health_services_research Not Available completed NCT04300361
Identifying Novel Variants in the DPYD Gene in Patients of Non-Western Descent No drug interventions Not Available Not Available unknown_status NCT00024661
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors treatment 1 completed NCT02202928
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer No drug interventions treatment 2 unknown_status NCT06270628
Personalized Live-remote Exercise Training for Cancer Survivors No drug interventions supportive_care Not Available not_yet_recruiting NCT01222728
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients No drug interventions Not Available Not Available completed NCT02690428
Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers No drug interventions treatment Not Available terminated NCT00145028
Determination of Carboplatin's Optimal Plasmatic Exposure Not Available Not Available completed NCT00496028
Phase I Study in Patients With Solid Tumours treatment 1 completed NCT00783328
A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors treatment 1 completed NCT02386111
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma treatment 1 terminated NCT00481611
Cancer Markers Associated With Occupational Exposure to Trichloroethylene No drug interventions Not Available Not Available completed NCT02660411
Impact of Anesthesia Maintenance Methods on Long-term Survival prevention Not Available completed NCT01905111
A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer treatment 1 completed NCT00962611
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer treatment 1 completed NCT00811993
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors treatment 1 terminated NCT01009593
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) treatment 3 terminated NCT03504293
The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions No drug interventions Not Available Not Available completed NCT01004393
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients supportive_care 2 completed NCT03096093
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT03967093
A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors treatment 1 terminated NCT05077371
Peer Support Program in Cancer Patients Elkar Laguntza No drug interventions supportive_care Not Available recruiting NCT00327171
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer treatment 2 completed NCT02836171
Effect of Itraconazole on the Pharmacokinetics of Apatinib treatment 1 completed NCT04342871
An Evaluation of the Families Addressing Cancer Together (FACT) Intervention No drug interventions supportive_care Not Available completed NCT01146171
Japanese Phase 1 Study of BMS-844203 (CT322) treatment 1 withdrawn NCT02889978
The Circulating Cell-free Genome Atlas Study No drug interventions Not Available Not Available active_not_recruiting NCT02944578
Topical Curcumin for Precancer Cervical Lesions treatment 2 suspended NCT02629978
Radiofrequency Ablation of Malignant Pulmonary Nodules No drug interventions treatment Not Available unknown_status NCT03269578
Sample Collection and Tracking for the Developmental Therapeutics Clinic No drug interventions Not Available Not Available recruiting NCT02897778
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors treatment 1 completed NCT02555878
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants prevention 3 completed NCT00033878
Study of Noni in Cancer Patients No drug interventions treatment 1 completed NCT03918278
A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) treatment 1 active_not_recruiting NCT04568278
Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment. No drug interventions supportive_care Not Available unknown_status NCT03666988
First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL) No drug interventions treatment 1 terminated NCT05256888
Time-Restricted Eating to Address Persistent Cancer-Related Fatigue No drug interventions supportive_care Not Available active_not_recruiting NCT00670488
Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002) treatment 1 completed NCT00606788
Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning No drug interventions treatment Not Available suspended NCT04067388
iKnife REIMS Project No drug interventions Not Available Not Available recruiting NCT05593107
68Ga-N188 PET/CT Imaging in Malignancy No drug interventions diagnostic Not Available recruiting NCT06464107
Endometrial Cell Collection With the PadKit No drug interventions screening Not Available recruiting NCT02964507
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer treatment 1 terminated NCT00074607
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine treatment 1 terminated NCT00822809
CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers treatment 3 completed NCT04461509
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy other 2 active_not_recruiting NCT04152109
Integrative and Complementary Health Practices (PICS) No drug interventions treatment Not Available recruiting NCT00046709
Marijuana for Cancer Pain treatment 1 / 2 terminated NCT05653609
Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring Tool No drug interventions Not Available Not Available completed NCT01335256
Clinical Study to Evaluate Safety and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced Malignancies treatment 1 completed NCT05733156
Abscopal Effect From the Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic Radiotherapy No drug interventions treatment Not Available recruiting NCT04721756
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging No drug interventions diagnostic 0 unknown_status NCT03269656
Age Gene/Environment Susceptibility Reykjavik Study No drug interventions Not Available Not Available completed NCT00475956
Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours treatment 1 completed NCT01471756
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia No drug interventions treatment 4 completed NCT02293785
GREAT - Good Response With Appropriate Treatment Not Available Not Available completed NCT01145885
BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours treatment 1 completed NCT00302185
Acupuncture in Palliative Cancer Care No drug interventions treatment 3 completed NCT01338285
Association of Formaldehyde Exposure to Myeloid Leukemia in Workers in Guangdong, China No drug interventions Not Available Not Available completed NCT02861885
Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right Colon No drug interventions Not Available Not Available unknown_status NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors treatment 1 / 2 completed NCT05155215
Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma treatment 1 / 2 unknown_status NCT00293215
Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen treatment 1 terminated NCT00043615
Collection of Blood, Bone Marrow, Tumor or Tissue Samples No drug interventions Not Available Not Available completed NCT04644315
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors treatment 2 terminated NCT03694015
SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases No drug interventions treatment Not Available recruiting NCT01684215
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer treatment 2 completed NCT04312737
Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus No drug interventions Not Available Not Available completed NCT02215837
Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer No drug interventions treatment 2 unknown_status NCT03521037
Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor other 1 completed NCT05944237
HTL0039732 in Participants With Advanced Solid Tumours treatment 1 / 2 recruiting NCT03566732
ERANet-LAC CODE: International Care Of the Dying Evaluation No drug interventions Not Available Not Available completed NCT03699332
Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin diagnostic 1 / 2 unknown_status NCT01962532
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma treatment 1 completed NCT00678132
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers treatment 1 completed NCT02078752
A Study Of PF-06647263 In Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer treatment 2 unknown_status NCT00386152
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy treatment 2 terminated NCT03760952
Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling No drug interventions Not Available Not Available completed NCT02909452
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 completed NCT06271252
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study treatment 1 recruiting NCT01168752
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma No drug interventions treatment 1 completed NCT00102752
Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer treatment 1 / 2 completed NCT02324452
Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines treatment Not Available completed NCT02646852
A Phase I Study of PLX038 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT01427400
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction treatment 4 unknown_status NCT02783300
An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma treatment 1 completed NCT06354959
Prehab for Lung and Esophageal Cancer No drug interventions supportive_care Not Available recruiting NCT03561259
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects treatment 2 recruiting NCT00094159
Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors treatment 1 completed NCT05940259
68Ga-P3 PET/CT Imaging in Prostate No drug interventions diagnostic Not Available recruiting NCT06005259
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) prevention 4 not_yet_recruiting NCT01462175
A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia treatment 1 completed NCT00428675
A New Tool for Assessing Fatigue in Individuals With Advanced Cancer No drug interventions Not Available Not Available completed NCT05280275
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible treatment 1 / 2 recruiting NCT04964375
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor No drug interventions treatment 1 unknown_status NCT04679675
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial No drug interventions health_services_research Not Available completed NCT01562275
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT06362070
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy No drug interventions treatment Not Available recruiting NCT00838370
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines prevention 1 completed NCT04144842
Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017 No drug interventions treatment 1 completed NCT01555242
A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas No drug interventions treatment 1 completed NCT00161642
Study Evaluating CMD-193 in Advanced Malignant Solid Tumors No drug interventions treatment 1 completed NCT01885299
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT No drug interventions Not Available Not Available recruiting NCT02666599
Per-operating Use of a Probe for Detection of β+ No drug interventions diagnostic Not Available terminated NCT04930406
Impact of Physical Therapy Intervention on Foot and Ankle Function No drug interventions Not Available Not Available recruiting NCT02908906
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers treatment 1 / 2 active_not_recruiting NCT00034606
Comparing 3 Schedules of Alimta Plus Gemzar treatment 2 completed NCT01538706
Hospital-based Home Care for Children With Cancer No drug interventions supportive_care Not Available completed NCT01270906
Safety of CHIR-258 (TKI258) in Advanced Solid Tumors treatment 1 terminated NCT00557206
Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer treatment 2 terminated NCT02004106
A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT04991506
A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT00270049
Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia treatment 2 completed NCT00454649
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor treatment 1 completed NCT05377749
The Families Addressing Cancer Together Intervention for Parents With Cancer No drug interventions supportive_care Not Available completed NCT06105749
Biennial CEM in Women With a Personal History of Breast Cancer No drug interventions screening Not Available recruiting NCT01037049
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks No drug interventions other 2 unknown_status NCT02854449
Tumor Response in Hypofractionated Radiotherapy No drug interventions Not Available Not Available unknown_status NCT02420249
Qigong for Breast Cancer Survivors No drug interventions treatment Not Available unknown_status NCT00001449
A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients treatment 1 completed NCT02454036
Biobehavioral Intervention in Gynecologic Oncology Patients No drug interventions supportive_care 2 completed NCT00877136
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® No drug interventions Not Available Not Available completed NCT03387436
The "Hand-in-Hand Study": Improvement of Quality of Life in Palliative Cancer Patients Through Collaborative Advance Care Planning No drug interventions supportive_care Not Available unknown_status NCT05918536
Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality No drug interventions Not Available Not Available recruiting NCT00388336
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy treatment 2 completed NCT01317836
PET-CT in Diagnosis of Pancreatic Cystic Neoplasms No drug interventions Not Available Not Available completed NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC treatment 2 active_not_recruiting NCT00277836
Study Evaluating MST-997 in Advanced Malignant Solid Tumors treatment 1 terminated NCT00569036
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors treatment 1 completed NCT05716113
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL No drug interventions treatment 0 recruiting NCT00980213
Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland Not Available Not Available completed NCT02606513
MR Urography vs CT Urography No drug interventions diagnostic Not Available completed NCT01233713
Hartmann's Versus Primary Anastomosis in Left-sided Colon Perforation No drug interventions treatment 2 / 3 completed NCT04288518
Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose. No drug interventions diagnostic 1 / 2 completed NCT01259518
Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas No drug interventions treatment 1 unknown_status NCT02810418
Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors treatment 1 / 2 completed NCT00817518
A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors treatment 1 completed NCT02116218
Assessment of Cancer Pain in Emergency Department in Traditional Chinese Medicine No drug interventions treatment Not Available withdrawn NCT00859118
Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies treatment 1 completed NCT02807519
Salivary Cytokines as Biomarker for Oral Health No drug interventions Not Available Not Available completed NCT03373019
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) treatment 2 unknown_status NCT00979641
Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer treatment 2 terminated NCT02292641
Beyond TME Origins No drug interventions treatment Not Available recruiting NCT02379741
ADC-1013 First-in-Human Study treatment 1 completed NCT02145741
Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours treatment 1 completed NCT02721641
A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer treatment 3 completed NCT01976741
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib) treatment 1 completed NCT06346041
Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT00273741
Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients treatment 3 terminated NCT06494241
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study No drug interventions Not Available Not Available not_yet_recruiting NCT00216541
A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy treatment 4 completed NCT01519817
Cancer Vaccine Targeting Brachyury Protein in Tumors treatment 1 completed NCT01881217
First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid Tumors No drug interventions treatment 1 completed NCT06289517
PET Imaging of 68Ga-Her2-affibody in Tumors With High Her2 Expression No drug interventions diagnostic Not Available not_yet_recruiting NCT04157517
A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors other 1 / 2 completed NCT02155634
Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma treatment 3 withdrawn NCT01313234
Educational Intervention Targeting Nurses Attitudes and Knowledge About Cancer-related Pain Management No drug interventions health_services_research Not Available completed NCT03945734
Expressive Helping for Chinese-Speaking Cancer Patients and Survivors No drug interventions supportive_care Not Available completed NCT03092934
A Study of AK-01 (LY3295668) in Solid Tumors treatment 1 / 2 completed NCT00048334
Depsipeptide to Treat Thyroid and Other Advanced Cancers treatment 1 completed NCT05839834
Blood Cell RNA-Based Cancer Detection No drug interventions Not Available Not Available recruiting NCT00599924
Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors treatment 1 completed NCT03792724
Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors treatment 1 / 2 unknown_status NCT00113724
Study of TPI 287 in Patients With Advanced Malignancies treatment 1 completed NCT02111824
A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy diagnostic 1 terminated NCT00719524
AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor treatment 1 completed NCT03515824
Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) No drug interventions treatment 1 terminated NCT05490524
Smart Living Homes: GATEKEEPER System With Patients With Cancer and Dementia in Cyprus No drug interventions supportive_care Not Available unknown_status NCT00618124
A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together treatment 1 completed NCT05980416
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 treatment 1 recruiting NCT01605916
Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer treatment 1 completed NCT01206816
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours treatment 1 completed NCT02014116
A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body No drug interventions treatment 1 terminated NCT05100316
Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials No drug interventions other 2 terminated NCT01802996
Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury No drug interventions prevention 4 unknown_status NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells No drug interventions other 2 / 3 recruiting NCT05949996
Evaluation of a Program for Routine Implementation of Symptom Distress Screening and Referral in Cancer Care No drug interventions health_services_research Not Available recruiting NCT05636696
COMPANION: A Couple Intervention Targeting Cancer-related Fatigue No drug interventions supportive_care Not Available active_not_recruiting NCT03981796
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer treatment 3 active_not_recruiting NCT02215096
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer treatment 1 completed NCT03626896
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients No drug interventions device_feasibility Not Available completed NCT04371796
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC treatment 2 unknown_status NCT00761696
A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies treatment 1 completed NCT00046696
A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors. No drug interventions treatment 1 completed NCT00400296
A Study of R547 in Patients With Advanced Solid Tumors. treatment 1 completed NCT00106158
Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1 No drug interventions treatment 1 completed NCT00001158
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System No drug interventions Not Available Not Available completed NCT02158858
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis treatment 1 / 2 active_not_recruiting NCT02659358
Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer No drug interventions Not Available Not Available completed NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) treatment 2 active_not_recruiting NCT06003335
Increasing Physical Activity Through Personalised Motivational Messaging to Improve Cognitive Function in Lung Cancer Survivors No drug interventions health_services_research Not Available not_yet_recruiting NCT00050635
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea prevention 4 completed NCT00046735
Phase 1 Study OF CDC-501 in Patients With Solid Tumors treatment 1 completed NCT02706535
A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential treatment 1 completed NCT04659135
ASCO Survey on COVID-19 in Oncology (ASCO) Registry No drug interventions Not Available Not Available active_not_recruiting NCT01156935
Effects of Laugh-yoga Intervention on Mood and Quality of Life Among Oncologic Patients in a Oncologic Clinic Setting. No drug interventions supportive_care Not Available unknown_status NCT01409135
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4 treatment 1 completed NCT02171663
Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors treatment 1 completed NCT02984163
Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study No drug interventions supportive_care Not Available recruiting NCT02442063
Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions Not Available 1 completed NCT04932863
BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment Not Available Not Available unknown_status NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma treatment 1 completed NCT03948763
A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) treatment 1 completed NCT05534386
A Self-management Based Survivorship Intervention for Chinese Cancer Survivors No drug interventions treatment Not Available recruiting NCT05322486
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases No drug interventions Not Available Not Available unknown_status NCT00104286
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors treatment 1 / 2 terminated NCT00487786
Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer treatment 1 completed NCT00213239
A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children treatment 1 / 2 completed NCT02360839
The Use of FNA and FNB in the Optimization of EUS-assisted Tissue Sampling No drug interventions diagnostic Not Available completed NCT00838539
Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors treatment 1 completed NCT05431439
Omics of Cancer: OncoGenomics No drug interventions Not Available Not Available withdrawn NCT04833439
The Effect of a Fasting MimickINg Diet on the Immune System No drug interventions basic_science Not Available completed NCT01445522
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer treatment 1 completed NCT05980325
Exercise For Fighting Oncology Repercussions After Treatment No drug interventions treatment Not Available not_yet_recruiting NCT02747225
Measuring the Electrical Properties of Malignant Tissues In Vivo No drug interventions Not Available Not Available unknown_status NCT02168725
Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors treatment 1 terminated NCT00195325
Study Evaluating TTI-237 in Advanced Malignant Solid Tumors. educational_counseling_training 1 terminated NCT00606125
Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors treatment 1 completed NCT01324830
Monotherapy Dose Finding With BI 847325 in Solid Tumours No drug interventions treatment 1 completed NCT05860530
Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers treatment Not Available completed NCT03360630
Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC No drug interventions treatment 1 / 2 completed NCT06094530
18F-FAPI-RGD PET/CT in Various Tumor Types No drug interventions Not Available Not Available recruiting NCT01297530
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies No drug interventions treatment 1 terminated NCT03330730
Evaluation of the Efficiency of the IsereADOM Home-care Service Package in the Prevention of Unplanned Hospitalizations of Patients With Cancer No drug interventions prevention Not Available completed NCT01964430
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) treatment 3 completed NCT04495530
Information Needs Around Parenteral nUTrition in Cancer No drug interventions Not Available Not Available completed NCT05874648
PRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early Detection No drug interventions Not Available Not Available not_yet_recruiting NCT01419548
ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems treatment 1 withdrawn NCT00343148
Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid No drug interventions treatment 1 completed NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice No drug interventions Not Available Not Available terminated NCT01255748
Registry Study for Radiation Therapy Outcomes No drug interventions Not Available Not Available recruiting NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) treatment 2 recruiting NCT02862457
Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434) treatment 1 completed NCT03602157
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL treatment 1 recruiting NCT03065257
Endoscopic Resection Multicenter Registry No drug interventions Not Available Not Available unknown_status NCT06505057
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients (HKCH) No drug interventions other Not Available recruiting NCT02528357
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1) treatment 1 completed NCT00265057
Study of ADH-1 Given Intravenously to Patients With Solid Tumors treatment 1 / 2 completed NCT03470857
Oxidoreductive Balance and Lysosomal Activity in Cancer Patients. No drug interventions Not Available Not Available completed NCT05834426
Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers No drug interventions Not Available Not Available not_yet_recruiting NCT01562626
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors treatment 1 / 2 suspended NCT01251926
EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors treatment 1 completed NCT02194426
First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients treatment 1 / 2 completed NCT03889626
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer treatment 3 unknown_status NCT03084926
First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid Tumors No drug interventions treatment 1 completed NCT02330926
Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy prevention 3 completed NCT02636426
Sorafenib Administered Using a High-dose, Pulsatile Regimen: a Phase I Exposure Escalation Study treatment 1 completed NCT06581666
Current Awareness, Perspective and Knowledge on Social Egg Freezing No drug interventions Not Available Not Available recruiting NCT01986166
A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS treatment 1 completed NCT05667766
Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC) No drug interventions supportive_care Not Available recruiting NCT02405065
Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573 No drug interventions treatment 1 completed NCT02005965
Low Rectal Cancer Study (MERCURY II) No drug interventions Not Available Not Available unknown_status NCT05176665
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers treatment 1 / 2 recruiting NCT00651365
A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors. treatment 1 terminated NCT05272865
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC other 1 / 2 not_yet_recruiting NCT06247865
BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE No drug interventions Not Available Not Available recruiting NCT03422874
Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma treatment 1 withdrawn NCT02345174
Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors No drug interventions other 1 completed NCT01008774
START: Swiss Taxotere Alopecia Prevention Trial No drug interventions prevention Not Available completed NCT05578274
Abscopal Effect From Low-dose Radiotherapy in Metastatic Cancer Combined With Stereotactic Body Radiotherapy No drug interventions treatment Not Available not_yet_recruiting NCT01362374
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors treatment 1 completed NCT01992874
Relative Bioavailability of Pimasertib in Cancer Patients treatment 1 completed NCT03102320
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors treatment 1 completed NCT01778920
Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) No drug interventions diagnostic 1 completed NCT04949282
Spanish Series of Patients Treated With the Radionuclide Lutetium177 Not Available Not Available recruiting NCT01481831
Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting treatment 4 completed NCT04635631
STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS treatment 1 completed NCT00031031
Kanglaite Injection Phase I Study No drug interventions treatment 1 completed NCT02031731
The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT03549273
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions No drug interventions treatment 2 recruiting NCT00057473
A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors treatment 2 completed NCT02754973
Integrated Experiential Training Program With Coaching by Nursing Students in Childhood Cancer Patients No drug interventions supportive_care Not Available completed NCT01682473
A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies No drug interventions treatment 1 completed NCT01655927
Efficacy of Tranexamic Acid in Brain Tumor Resections treatment 3 unknown_status NCT00167427
Genotoxicity Assessment for Patients Undergoing Radiation Treatment No drug interventions Not Available Not Available completed NCT02620527
Concordance Between ctDNA Assay and FoundationOne No drug interventions Not Available Not Available completed NCT02732327
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer treatment 2 terminated NCT00027027
Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors No drug interventions treatment 1 completed NCT03535727
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT03210727
CAREgiver Study for Patients Undergoing HSCT No drug interventions supportive_care Not Available completed NCT00479076
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients treatment 1 completed NCT04706676
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer No drug interventions prevention Not Available recruiting NCT02171676
BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors treatment 1 completed NCT00095160
Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors No drug interventions treatment 1 completed NCT02895360
Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma treatment 1 / 2 completed NCT02017860
Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator. treatment 2 completed NCT02891460
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients No drug interventions treatment Not Available completed NCT04009460
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT02606994
Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis treatment 2 terminated NCT02486094
Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging No drug interventions Not Available Not Available completed NCT00005494
Prospective Study of Health in Runners and Walkers No drug interventions Not Available Not Available completed NCT05704894
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens treatment 3 not_yet_recruiting NCT00962494
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors No drug interventions supportive_care 2 completed NCT02824094
Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC Not Available Not Available no_longer_available NCT02372994
My Team of Care: a Pilot Randomized Controlled Trial of an Online Communication Tool for Collaborative Care No drug interventions supportive_care Not Available completed NCT05895994
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies No drug interventions treatment 0 recruiting NCT03564691
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) treatment 1 active_not_recruiting NCT03797391
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors treatment 1 / 2 recruiting NCT00037791
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia No drug interventions prevention 3 completed NCT00256191
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies treatment 1 completed NCT00219791
Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance treatment 2 completed NCT03872362
Radiomics Multifactorial Biomarker for Pulmonary Nodules No drug interventions Not Available Not Available completed NCT04349280
A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer treatment 1 terminated NCT00048880
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein No drug interventions treatment 1 completed NCT00135980
Integrated Care for Cancer Patients; Developing, Implementing and Testing a Programme to Improve Integrated Care No drug interventions educational_counseling_training Not Available unknown_status NCT00830180
Open Label Extension In Cancer Patients No drug interventions treatment 2 completed NCT01576380
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients treatment 2 completed NCT00259129
Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients Not Available 1 completed NCT00207129
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies treatment 1 completed NCT03143829
Promoting Cancer Symptom Management in Older Adults No drug interventions supportive_care Not Available completed NCT04746729
Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy No drug interventions Not Available Not Available recruiting NCT05712889
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer No drug interventions treatment 1 recruiting NCT04989192
Dose Efficiency of Modern CT Scanners in Oncologic Scans No drug interventions diagnostic Not Available unknown_status NCT05882292
A Phase II Study of ABN401 in Advanced Solid Tumors With c-MET Gene Aberration No drug interventions treatment 2 not_yet_recruiting NCT05013944
AnovaOS Network Powered Patient Registry No drug interventions Not Available Not Available recruiting NCT00560144
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors. treatment 1 completed NCT04991740
A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors No drug interventions treatment 1 completed NCT00046540
Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer treatment 1 completed NCT06004440
Real World Registry for Use of the Ion Endoluminal System No drug interventions Not Available Not Available recruiting NCT03096340
Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer No drug interventions treatment 1 terminated NCT00309140
An Open Label Study of Oral Enzastaurin in Participants With Cancer treatment 2 completed NCT03351140
Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function No drug interventions Not Available Not Available completed NCT05440240
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture No drug interventions treatment 4 recruiting NCT05022667
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy No drug interventions prevention Not Available recruiting NCT03336567
Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer No drug interventions Not Available Not Available completed NCT04509167
Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms No drug interventions treatment 0 completed NCT00106067
Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients No drug interventions supportive_care Not Available completed NCT01837667
Phase I Study of LB-100 With Docetaxel in Solid Tumors treatment 1 completed NCT05307367
Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms No drug interventions basic_science Not Available recruiting NCT01226901
A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) treatment 1 terminated NCT02265601
End-of-Life Health Care Decisions by Patients With Advanced Cancer No drug interventions other Not Available completed NCT03329001
Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule treatment 1 completed NCT01186601
Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer No drug interventions diagnostic 1 completed NCT04006301
First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation No drug interventions treatment 1 completed NCT03510104
Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT01339104
Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity treatment 1 completed NCT02635672
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer treatment 1 active_not_recruiting NCT01901172
A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors Not Available 1 completed NCT02861872
Intra-peritoneal Chemotherapy in Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT01973868
Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination treatment 1 completed NCT02720068
Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) treatment 1 completed NCT00001668
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors No drug interventions Not Available Not Available completed NCT06256068
Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a Study Protocol No drug interventions Not Available Not Available not_yet_recruiting NCT03424668
The European Prospective Investigation Into Cancer in Norfolk Prospective Population Study No drug interventions Not Available Not Available active_not_recruiting NCT05160168
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) treatment 1 / 2 terminated NCT02324868
Impact of Availability of Showerpatch for Patients With Intravenous Catheters No drug interventions supportive_care Not Available terminated NCT03553368
Chest Imaging of Lung Nodule(s) Under High-frequency Non-invasive Ventilation (HF-NIV) No drug interventions diagnostic Not Available completed NCT00880568
Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED) treatment 1 completed NCT01891669
A Study Of PF-06263507 In Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT02380469
Improvement of Information to Cancer Patients' Caregivers No drug interventions health_services_research Not Available completed NCT05374369
Retrospective Analysis of Colorectal Cancer Screening Results No drug interventions Not Available Not Available completed NCT01335269
A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer treatment 1 completed NCT01164046
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism treatment 3 terminated NCT02341846
Exploring New Technologies to Manage Cancer Pain in the Community No drug interventions Not Available Not Available completed NCT00264446
A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection No drug interventions treatment 1 completed NCT01472146
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer treatment 2 completed NCT01591746
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction supportive_care 3 completed NCT01938846
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT03328546
Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer) No drug interventions Not Available Not Available completed NCT00545246
A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients treatment 1 completed NCT02747212
Measuring the Electrical Properties of Malignant Tissues Ex Vivo No drug interventions Not Available Not Available unknown_status NCT06058312
Individual Food Preferences for the Mediterranean Diet in Cancer Patients No drug interventions supportive_care Not Available recruiting NCT02514512
Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking No drug interventions treatment Not Available active_not_recruiting NCT02588612
Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT00954512
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) treatment 1 / 2 terminated NCT03573310
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS No drug interventions treatment 1 active_not_recruiting NCT04085510
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania No drug interventions screening Not Available active_not_recruiting NCT00566410
A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours treatment 1 completed NCT00300781
Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer treatment 2 completed NCT05538481
Study to Identify and Measure the Values and Palliative Care Pref. of Hindu Patients and Their Caregivers No drug interventions Not Available Not Available withdrawn NCT00264095
An Observational Study of Blood Management Techniques in Oncology Surgical Treatment No drug interventions Not Available Not Available completed NCT00001495
A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors treatment 1 completed NCT04544995
Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Pediatric Participants With Solid Tumors (SCOOP) treatment 1 suspended NCT05209295
A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies basic_science 1 recruiting NCT04448314
Study to Evaluate the Usability of PointCheck No drug interventions Not Available Not Available completed NCT03156114
This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment. treatment 1 completed NCT00706355
A Study of PF-04217903 in Patients With Advanced Cancer treatment 1 terminated NCT04722055
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China No drug interventions Not Available Not Available completed NCT03333655
Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy No drug interventions basic_science 4 completed NCT01657955
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia treatment 3 unknown_status NCT03810755
EfiKroniK Research Program: Physical Exercise for People With Chronic Pathologies No drug interventions treatment Not Available completed NCT01273155
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction treatment 1 completed NCT02723955
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) treatment 1 completed NCT04596150
Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer treatment 2 completed NCT00225550
A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors treatment 1 / 2 terminated NCT06187350
The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland No drug interventions Not Available Not Available recruiting NCT05235750
Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer No drug interventions prevention Not Available completed NCT03972150
A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer treatment 1 completed NCT00034450
Developmental Study on Fatigue in Cancer treatment 2 completed NCT02123823
BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer treatment 1 completed NCT01065623
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01767623
A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants treatment 1 completed NCT00562523
Sorafenib/Docetaxel Dose Escalation Trial treatment 1 completed NCT03967223
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors treatment 2 active_not_recruiting NCT00046423
A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies treatment 1 completed NCT06001723
A Feasibility Study to Determine Whether the Botanical Garden Become a Region of Forest Therapy for Cancer Survivors No drug interventions supportive_care Not Available completed NCT05553808
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1 treatment 2 completed NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT00264108
Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia Not Available Not Available completed NCT01081808
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01322438
Effect of Rifampin on the Pharmacokinetics of BAY73-4506 basic_science 1 completed NCT04626843
Intermittent Fasting and CLL/SLL No drug interventions treatment 1 completed NCT04630743
Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease No drug interventions other Not Available completed NCT05592743
Vorasidenib Expanded Access Program Not Available Not Available available NCT06128343
Anatomical-Clinical Base of Adenocarcinoma Pancreatic No drug interventions Not Available Not Available recruiting NCT01938443
A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors treatment 1 completed NCT06322693
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) treatment 1 recruiting NCT04545827
Study to Evaluate the Safety of IMM-01 in Patients With Advanced Solid Tumours basic_science 1 not_yet_recruiting NCT03816254
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, With Cetuximab in Subjects With Advanced Solid Cancers treatment 1 not_yet_recruiting NCT02810431
Long Term Retention of Protspectively Obtained Biospecimens No drug interventions Not Available Not Available completed